DULUTH, Ga. — Boehringer Ingelheim Animal Health has announced the appointment of Randolph Legg as its U.S. president. He succeeds Everett Hoekstra, who retired in December. Legg will remain head of the company's U.S. commercial business while serving as president.
"It's my honor to lead an organization dedicated to enhancing the well-being of people and animals," he said.
Legg held various commercial leadership roles in Boehringer Ingelheim's Human Pharmaceutical division before moving to the company's Animal Health business in 2019 to lead the U.S. Pets Commercial team. He is based at the U. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
